Beijing and Brussels are entering negotiations to resolve disputes related to electric vehicles.
Prosus reported an 84% jump in full-year core net profit.
ArgenX shares rose by 8% this morning after announcing FDA approval of Vyvgart Hytrulo for chronic inflammatory demyelinating polyneuropathy …
© MarketScreener.com 2024
Prosus reported an 84% jump in full-year core net profit.
ArgenX shares rose by 8% this morning after announcing FDA approval of Vyvgart Hytrulo for chronic inflammatory demyelinating polyneuropathy …
© MarketScreener.com 2024